Curis Inc
CRIS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001108205
No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.
Key figures
- Market capClose on Nov 10, 2026
- $1.36M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −4 vs. previous quarter
- 39
- 13F valueReported value at the end of Q2 2026
- $7.96M
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $9.44M
- −13.4% year over year
- Net income, FY2025
- -$7.58M
- No comparable prior period
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q2 FY2026
- $0
- −100.0% year over year
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.03M
- Shares sold short
- Change
- +590.1K
- +134.3% vs. previous
- Days to cover
- 1.12
- At average daily volume
Superinvestors holding CRIS, Q2 2026
Go to the superinvestors tab1 superinvestor reports holding Curis Inc on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Curis Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Kaitin Kenneth IDirector | PPurchase | +10.0K | $0.55 | +$5.50K | +710.7%11.4K after | |
| Jan 31, 2022 (view filing) | Jan 27-31 | 4 days | Dentzer James EPresident & CEO | SSale | −5.50K | $3.12 | −$17.1K | −7.8%64.9K after | 2 lots |
Top 10 13F holders, Q2 2026
See all 39 holdersThe largest institutional positions in Curis Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bleichroeder LP | 3,802,329 | $1.99M | 0.36% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 3,312,185 | $1.73M | 1.32% | −414,221−11.1% | Reduced |
| Sphera Funds Management Ltd. | 98,996 | $1.03M | 0.15% | −1,895,941−95.0% | Reduced |
| Nantahala Capital Management, LLC | 1,978,876 | $1.03M | 0.06% | −21,124−1.1% | Reduced |
| Cable Car Capital LLC | 1,333,334 | $696.1K | 0.01% | 00.0% | Unchanged |
| CM Management, LLC | 550,000 | $287.2K | 0.18% | +400,000+266.7% | Added |
| Morgan Stanley | 504,292 | $263.3K | 0.00% | +250,047+98.3% | Added |
| Vanguard Capital Management LLC | 343,842 | $179.5K | 0.00% | −30,484−8.1% | Reduced |
| Geode Capital Management, LLC | 293,097 | $153.0K | 0.00% | +124,770+74.1% | Added |
| M28 Capital Management LP | 284,889 | $148.7K | 0.32% | 00.0% | Unchanged |
Holders of 5% or more of CRIS
See all 6 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Curis Inc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 13G | 9.99%4.22M shares | 0.00 ppfrom 9.99% | Apr 7, 20262 filings | Apr 24, 2026 | SEC |
| Armistice Capital, LLC | 13G/A | 9.99%1.29M shares | – | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
| Stonepine Capital Management, LLC | 13G | 9.90%4.03M shares | New | Mar 27, 20261 filing | Mar 27, 2026 | SEC |
| Bleichroeder LP | 13G | 9.90%1.04M shares | New | Mar 31, 20251 filing | Mar 31, 2025 | SEC |
| Satterfield Thomas A Jr | 13G/A | 8.80%616.6K shares | −1.10 ppfrom 9.90% | Nov 1, 20245 filings | Nov 10, 2026 | SEC |